What is letrozole 2.5 mg used for?
Letrozole 2.5 mg tablets are used to treat hormone receptor–positive breast cancer in postmenopausal patients. The drug lowers estrogen levels by blocking the enzyme aromatase, which reduces cancer growth driven by estrogen [1].
How is letrozole used in breast cancer treatment?
Letrozole is prescribed for:
- Early breast cancer (as part of hormone therapy, often given after surgery)
- Advanced or metastatic hormone receptor–positive breast cancer
Its role is to reduce estrogen stimulation of the tumor [1].
Who typically takes letrozole 2.5 mg?
Letrozole is mainly used in postmenopausal patients with estrogen receptor–positive breast cancer [1]. (Use in premenopausal patients is more limited and depends on specific clinical scenarios and specialist guidance.)
What are common side effects patients ask about?
Patients commonly report symptoms linked to lowered estrogen, such as hot flashes, joint or muscle pain, fatigue, and sometimes bone thinning/osteoporosis risk. Clinicians may monitor bone density during treatment [1].
Is letrozole ever used for conditions other than breast cancer?
Letrozole has been used in other settings in medicine, but the specific, approved and standard use for the 2.5 mg tablet is breast cancer hormone therapy in the indicated patient population [1].
Where to check dosing and product-specific information
For product labeling, dosing details, and patent/drug background, you can also review pages like those hosted by DrugPatentWatch.com: DrugPatentWatch.com for letrozole [1].
Sources
[1] https://www.drugpatentwatch.com/